The aviation sector around the world is still feeling the effects of the COVID-19 pandemic and faces the great challenge of getting through this period of time, while many aircraft remain on the ground. Several airlines have stopped flying altogether, while others have reduced their capacity or seen their market decline. For the companies that…
EyePoint Pharmaceuticals, Inc. ($EYPT) is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. Recent developments equals happy investors? A little month ago, its share rose with 35% on the premarket after expanding its…
For months the world has been under the spell of the COVID-19 vaccine race, as society is very anxious to see which pharmaceutical company will be the first to complete its Phase 3 study. A live tracker has been published on the website of The New York Times to see which pharmaceuticals are in which…
Investor sentiment is based on discussions and interactions between social media market participants regarding the stock market. Plug Power ($PLUG) has received very positive discussions over the past two weeks. On nine days, the mood barometer was green, negative discussions could not be recorded. Investors were largely neutral for a total of five days. Currently,…
XpresSpa Group ($XSPA) is the world’s largest provider of airport spa facilities and had to come up with a new market strategy as the coronavirus ravages the world. Where the share steadily increased at the beginning of this year, soon after the spread of the virus it became clear that the company had to change…
Breakout Stocks Corona Virus Stocks FingerMotion Inc – FNGR OTCQB These shares are speculative and closely held . The shares could move quickly and advance to much higher levels should their business model be successfully executed. The company reported over $9 million in yearly revenues for 2020 up 520%. Gross profits almost doubled Q1 2021 FNGR reported $2.74…
This morning pharmaceutical and medicine giant AstraZeneca ($AZN) announced an immediate interruption of the COVID-19 vaccine test during the Phase 3 study, after a participant in from the UK showed severe neurological symptoms of an unexplained disease. As a result, the company has discontinued the standard process in order to review the safety data first.…
Novavax, Inc. ($NVAX) has been one of the biggest pioneers on the pharmaceutical market since the outbreak of the COVID-19 pandemic. This is mainly due to the extreme increase that the NVAX share has seen this year, by growing with a sensational 2000%. As several biotech companies have begun phase 3 clinical trials for an…
Vaxart, Inc. ($VXRT) – a well-known clinical stage biotechnology company developing oral recombinant vaccines that are administered via tablets rather than injections – is breaking the news this morning. The COVID-19 vaccine candidate has shown encouraging results in preclinical research. Vaxart is now announcing a pre-publication of a manuscript on this matter named: “Preclinical Studies…
Gevo, Inc. ($GEVO) knows several discussions in which a clear signal is given about the assessments and sentiments. At the moment the share is trending on various social media channels such as Stocktwits, RobinHood and Twitter. The comments and opinions of the past two weeks have been optimistic and positive in most cases. In addition,…
